Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort

Establishing the optimal treatment for COVID-19 patients remains challenging. Specifically, immunocompromised and pre-diseased patients are at high risk for severe disease course and face limited therapeutic options. Convalescent plasma (CP) has been considered as therapeutic approach, but reliable...

Descripción completa

Detalles Bibliográficos
Autores principales: Freise, Noemi F., Gliga, Smaranda, Fischer, Johannes, Lübke, Nadine, Lutterbeck, Matthias, Schöler, Miriam, Bölke, Edwin, Orth, Hans Martin, Feldt, Torsten, Roemmele, Christoph, Wilke, Dominik, Schneider, Jochen, Wille, Kai, Hohmann, Christian, Strauss, Richard, Hower, Martin, Ruf, Andreas, Schubert, Joerg, Isberner, Nora, Stecher, Melanie, Pilgram, Lisa, Vehreschild, Jörg J., Hanses, Frank, Luedde, Tom, Jensen, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643921/
https://www.ncbi.nlm.nih.gov/pubmed/36351986
http://dx.doi.org/10.1038/s41598-022-23200-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643921/
https://www.ncbi.nlm.nih.gov/pubmed/36351986
http://dx.doi.org/10.1038/s41598-022-23200-1

Ejemplares similares